HostPathEP hones in on the pathogen and host transcripts that matter, opening up new capabilities for transcriptomics in pathogenesis research, diagnostics, epidemiology, immunology, and more.
Be an early collaborator and one of the first to unlock host-pathogen selective enrichment; contact us to find out more and inquire about collaborations.
See where MultiTarga is revolutionizing selective enrichment. Multi-targeted Priming gives better results to existing assays and opens up unexplored opportunities to understand genes in a completely new light.
HostPathEP revolutionizes pathogen detection and diagnostics by dramatically enhancing sensitivity for low-abundance pathogens while simultaneously profiling host immune responses. This dual capability enables earlier, more comprehensive diagnosis and monitoring of infectious diseases, providing clinicians and researchers with a more complete picture of infection dynamics.
In host-pathogen interaction studies, our platform enables unprecedented insight into the molecular dialogue between host and pathogen. Researchers can simultaneously analyze gene expression patterns from multiple organisms, tracking infection progression, immune response dynamics, and the complex interplay of virulence factors and host defense mechanisms in real-time.
For epidemiological surveillance, HostPathEP provides a powerful tool to monitor pathogen evolution and transmission patterns at the molecular level. This capability is crucial for tracking the emergence of variants, studying drug resistance development, and understanding host population susceptibility factors, ultimately contributing to better public health responses and containment strategies.
In drug development and testing, our platform offers unique advantages for evaluating therapeutic responses at the molecular level. Researchers can efficiently screen antimicrobial compounds while simultaneously monitoring both pathogen response and host effects, accelerating the development of more effective treatments and enabling early detection of drug resistance mechanisms.
See where MultiTarga is revolutionizing selective enrichment. Multi-targeted Priming gives better results to existing assays and opens up unexplored opportunities to understand genes in a completely new light.
Our team is committed to supporting your research success with HostPathEP. We provide comprehensive technical documentation, validation support, and expert consultation to ensure optimal results for your specific application. Whether you need assistance with experimental design, protocol optimization, or data analysis, our scientific team is ready to help. Contact us through our online form to discuss your research needs and learn how we can support your host-pathogen studies.
See where MultiTarga is revolutionizing selective enrichment. Multi-targeted Priming gives better results to existing assays and opens up unexplored opportunities to understand genes in a completely new light.